Raltegravir 800mg twice daily appears a good alternative to efavirenz for HIV-TB treatment
Why do surveys show that female sex workers have 14 times the risk of having HIV as other women?
Once-daily elvitegravir works as well as raltegravir at 96 weeks
Cobicistat matches ritonavir as atazanavir booster
Black gay men in the UK almost twice as likely to have HIV as white men, meta-analysis shows
Taking isoniazid preventive therapy for one year reduces the risk of TB in people taking antiretroviral therapy
First generic HIV drugs could save US at least $920 million a year
Latest data on HIV cure research
